Objectives Ethnicity and health outcomes are intrinsically interrelated, although mechanisms are complex. SLE is a disease ...
Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis.
Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability remain unclear. This study aimed to identify predictors of variability in ...
Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...
SLE is a chronic multisystem autoimmune disease in which cardiovascular disease is a leading cause of mortality, with a twofold to threefold greater risk than the general population.1 Hypertension ...
Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials (6 January, 2025) ...
No HTML tags allowed. Web page addresses and e-mail addresses turn into links automatically. Lines and paragraphs break automatically.